Anar al contingut
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Idioma
Tots els camps
Títol
Autor
Matèria
Signatura
ISBN/ISSN
Etiqueta
Trobar
Avançada
Karyotype is an independent pr...
Citar
Enviar aquest missatge de text
Enviar per correu electrònic aquest
Imprimir
Exportar registre
Exportar a RefWorks
Exportar a EndNoteWeb
Exportar a EndNote
Enllaç permanent
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia
Dades bibliogràfiques
Autors principals:
Moorman, A
,
Harrison, C
,
Buck, G
,
Richards, S
,
Secker-Walker, L
,
Martineau, M
,
Vance, G
,
Cherry, A
,
Higgins, R
,
Fielding, A
,
Foroni, L
,
Paietta, E
,
Tallman, MS
,
Wernik, P
,
Litzow, MR
,
Rowe, J
,
Goldstone, A
,
Dewald, G
Format:
Conference item
Publicat:
2007
Fons
Descripció
Ítems similars
Visualització del personal
Ítems similars
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia
per: Moorman, A, et al.
Publicat: (2007)
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial.
per: Moorman, A, et al.
Publicat: (2007)
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia (ALL): Analysis of cytogenetic data from 1,235 patients on the medical research council (MRC) UKALLXII/Eastern cooperative oncology group (ECOG) 2993 trial.
per: Moorman, A, et al.
Publicat: (2005)
Imatinib Significantly Enhances Long-Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia; Final Results of the UKALLXII/ECOG2993 Trial
per: Fielding, A, et al.
Publicat: (2010)
Imatinib Significantly Enhances Long Term Outcomes In Philadelphia Positive Acute Lymphoblastic Leukaemia, Final Results of the UKALLXII/ECOG2993 Trial
per: Fielding, A, et al.
Publicat: (2010)